BIOMAT Database Logo BIOMAT Database Logo

Quality control limits for microdilution susceptibility tests with norfloxacin. 1987

A L Barry, and T L Gavan, and L W Ayers, and P C Fuchs, and E H Gerlach, and C Thornsberry

A multilaboratory study was designed to define quality control limits for microdilution susceptibility tests with norfloxacin. The following limits were proposed: for Escherichia coli ATCC 25922, 0.03 to 0.125 micrograms/ml; for Pseudomonas aeruginosa ATCC 27853, 1.0 to 4.0 micrograms/ml; for Staphylococcus aureus ATCC 29213, 0.5 to 2.0 micrograms/ml; and for Streptococcus faecalis ATCC 29212, 2.0 to 8.0 micrograms/ml. The latter represents a change in the previously recommended control limits.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009643 Norfloxacin A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. AM-0715,AM-715,MK-0366,MK-366,MK0366,MK366,Noroxin,AM 0715,AM 715,AM0715,MK 0366,MK 366
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011786 Quality Control A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed) Control, Quality,Controls, Quality,Quality Controls
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013293 Enterococcus faecalis A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic. Streptococcus Group D,Streptococcus faecalis

Related Publications

A L Barry, and T L Gavan, and L W Ayers, and P C Fuchs, and E H Gerlach, and C Thornsberry
Quality control limits for broth microdilution susceptibility tests of ten antifungal agents.
September 2000, Journal of clinical microbiology,
A L Barry, and T L Gavan, and L W Ayers, and P C Fuchs, and E H Gerlach, and C Thornsberry
Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium.
January 1991, Diagnostic microbiology and infectious disease,
A L Barry, and T L Gavan, and L W Ayers, and P C Fuchs, and E H Gerlach, and C Thornsberry
Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing Group.
January 1989, Diagnostic microbiology and infectious disease,
A L Barry, and T L Gavan, and L W Ayers, and P C Fuchs, and E H Gerlach, and C Thornsberry
Revision of quality control limits for cefotaxime disk susceptibility tests.
May 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
A L Barry, and T L Gavan, and L W Ayers, and P C Fuchs, and E H Gerlach, and C Thornsberry
Broth microdilution susceptibility testing of Brucella species: quality control limits for ten antimicrobial agents against three standard quality control strains.
November 2005, Journal of clinical microbiology,
A L Barry, and T L Gavan, and L W Ayers, and P C Fuchs, and E H Gerlach, and C Thornsberry
Broth microdilution susceptibility testing of Francisella tularensis: quality control limits for nine antimicrobial agents and three standard quality control strains.
December 2004, Journal of clinical microbiology,
A L Barry, and T L Gavan, and L W Ayers, and P C Fuchs, and E H Gerlach, and C Thornsberry
Revision of quality control limits for broth microdilution tests of fleroxacin and gentamicin with Pseudomonas aeruginosa ATCC 27853.
December 1994, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
A L Barry, and T L Gavan, and L W Ayers, and P C Fuchs, and E H Gerlach, and C Thornsberry
Quality control parameters for broth microdilution tests of anidulafungin.
January 2004, Journal of clinical microbiology,
A L Barry, and T L Gavan, and L W Ayers, and P C Fuchs, and E H Gerlach, and C Thornsberry
Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.
January 2000, Journal of clinical microbiology,
A L Barry, and T L Gavan, and L W Ayers, and P C Fuchs, and E H Gerlach, and C Thornsberry
Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disks.
February 1984, Journal of clinical microbiology,
Copied contents to your clipboard!